NOTCH3 and ovarian carcinoma: Alterations in the Notch pathway are significantly associated with poor clinical outcomes in patients with ovarian cancer [23], and therefore we can speculate that the expression of miR-151, APH1A and the notch3 pathway may be correlated with the ovaries and associated with aging.